bimekizumab,Adalimumab
ucb pharmaceuticals,abbvie
['ucb_news']
for media: #ucb is presenting new long-term data in #psoriaticarthritis and #axialspondyloarthritis at #eular2023. find out more: 
A global biopharma company focusing on creating value for people living with neurology and immunology diseases. 
We are inspired by patients, driven by science.